Help us: Donate
Follow us on:
×

Menu

Back

Three Days Until the Second Longevity Therapeutics Conference

Longevity Therapeutics logoLongevity Therapeutics logo
 

The Longevity Therapeutics conference enters its second year, opening its doors on January 28th for a three-day event focused on aging research. If you are interested in the actual science happening in the field with no snake oil in sight, then this is the West Coast conference to attend.

With over 80 speakers, including researchers, biotech startup CEOs, investors, and pharmaceutical experts, it promises to be a very interesting event. Companies and institutions such as AgeX Therapeutics, Juvena therapeutics, Buck Institute for Research on Aging, ResTORbio, NIH, and Unity Biotechnologies will be presenting at the event.

Some of the highlights for the conference will be:

  • Unity Biotechnologies will be announcing its first-in-human trial results and its next steps for the future.
  • Juvena Therapeutics will be talking about how the use of quantitative proteomics and AI can accelerate preclinical development of rejuvenation therapies.
  • The Buck Institute for Research on Aging will be discussing the evidence for the role of cellular senescence in Alzheimer’s disease and the potential use of senolytics as therapeutics in its later stages.

Lifespan.io is an official media partner of the event, and our reporting team will be on site to bring you the latest industry news and interviews with the researchers, so stay tuned in the coming weeks as we publish articles from this event.

There are only three days left to register for what is sure to be an amazing conference packed with some of the leading minds in the field of rejuvenation biotechnology.

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
  1. jimofoz
    January 25, 2020

    Hope you get some good coverage and nice weather in California Steve (it’s got to beat UK weather right now).

Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.